help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichinose, M.
Right arrow Articles by Shirato, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichinose, M.
Right arrow Articles by Shirato, K.

Am. J. Respir. Crit. Care Med., Vol 154, No. 5, 11 1996, 1272-1276.

Incubation with IgE increases cholinergic neurotransmission in human airways in vitro

M Ichinose, M Miura, M Tomaki, T Oyake, N Kageyama, Y Ikarashi, Y Maruyama and K Shirato
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Airway cholinergic hyperresponsiveness is frequently observed in asthmatic patients. Recent reports suggest the possible involvement of IgE in hyperresponsiveness, although the exact mechanism is still uncertain. In this study, we examined whether incubation with IgE could facilitate the cholinergic function in human airways. Bronchi were obtained from 20 patients undergoing lung resection. Cholinergic contractile responses were induced by electrical field stimulation (EFS) or exogenous acetylcholine (ACh), and they were assessed by isometric tension measurement. EFS-induced ACh release from cholinergic nerves was also measured by high performance liquid chromatography. Incubation with IgE significantly enhanced EFS-induced bronchial contraction and ACh release as compared with the values of the bronchi incubated with heat inactivated IgE (control) (p < 0.05, respectively), but it did not alter the contractile responses induced by exogenous ACh. Pretreatment with the muscarinic M2-receptor agonist pilocarpine reduced the EFS-induced ACh release in the control tissues (p < 0.05), but not in the tissues incubated with IgE. The M2-receptor antagonist methoctramine significantly enhanced the EFS-induced contraction in control bronchi (p < 0.05), but this augmentation was not observed in the tissues incubated with IgE. These results suggest that IgE itself can enhance cholinergic bronchial contraction via facilitation of ACh release from cholinergic nerves and that this augmentation is related to autoreceptor M2 dysfunction at nerve endings.


This article has been cited by other articles:


Home page
Therapeutic Advances in Respiratory DiseaseHome page
M. Baroffio, E. Crimi, and V. Brusasco
Review: Airway smooth muscle as a model for new investigative drugs in asthma
Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 129 - 139.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. BLACK and P. R. A. JOHNSON
What Determines Asthma Phenotype? Is It the Interaction between Allergy and the Smooth Muscle?
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S207 - 210.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. F. RABE
Mechanisms of Immune Sensitization of Human Bronchus
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S161 - S170.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. W. Mitchell, K. F. Rabe, H. Magnussen, and A. R. Leff
Passive sensitization of human airways induces myogenic contractile responses in vitro
J Appl Physiol, October 1, 1997; 83(4): 1276 - 1281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society